Skip to main content

Brompheniramine / carbetapentane / phenylephrine Pregnancy and Breastfeeding Warnings

Brand names: BetaTan, Pulmari, Seradex, Trexbrom (old formulation), V-COF, Vazotan

Brompheniramine / carbetapentane / phenylephrine Pregnancy Warnings

Brompheniramine/carbetapentane/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Brompheniramine/carbetapentane/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Brompheniramine / carbetapentane / phenylephrine Breastfeeding Warnings

There are no data on the excretion of brompheniramine/carbetapentane/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Brompheniramine/carbetapentane/phenylephrine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. (2005) "Product Information. BetaTan (brompheniramine/carbetapentane/phenylephrine)." WraSer Pharmaceuticals

References for breastfeeding information

  1. (2005) "Product Information. BetaTan (brompheniramine/carbetapentane/phenylephrine)." WraSer Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer